These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31325604)

  • 1. Integrative Chinese herbal medicine therapy reduced the risk of type 2 diabetes mellitus in patients with polycystic ovary syndrome: A nationwide matched cohort study.
    Liao WT; Su CC; Lee MT; Li CJ; Lin CL; Chiang JH; Yen HR
    J Ethnopharmacol; 2019 Oct; 243():112091. PubMed ID: 31325604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prescription patterns of traditional Chinese medicine for women with polycystic ovary syndrome in Taiwan: A nationwide population-based study.
    Lin MJ; Chen HW; Liu PH; Cheng WJ; Kuo SL; Kao MC
    Medicine (Baltimore); 2019 Jun; 98(24):e15890. PubMed ID: 31192922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome.
    Joham AE; Ranasinha S; Zoungas S; Moran L; Teede HJ
    J Clin Endocrinol Metab; 2014 Mar; 99(3):E447-52. PubMed ID: 24081730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
    Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
    PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: the National Health Insurance Service-National Sample Cohort Study.
    Ryu KJ; Kim MS; Kim HK; Kim YJ; Yi KW; Shin JH; Hur JY; Kim T; Park H
    Fertil Steril; 2021 Jun; 115(6):1569-1575. PubMed ID: 33509630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of Chinese herbal medicine as an adjuvant therapy to reduce incidence of chronic hepatitis in colon cancer patients: A Taiwanese population-based cohort study.
    Lin TH; Yen HR; Chiang JH; Sun MF; Chang HH; Huang ST
    J Ethnopharmacol; 2017 Apr; 202():225-233. PubMed ID: 28330722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardised versus individualised multiherb Chinese herbal medicine for oligomenorrhoea and amenorrhoea in polycystic ovary syndrome: a randomised feasibility and pilot study in the UK.
    Lai L; Flower A; Prescott P; Wing T; Moore M; Lewith G
    BMJ Open; 2017 Feb; 7(2):e011709. PubMed ID: 28159846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study.
    Lu HL; Su YC; Lin MC; Sun MF; Huang ST
    Complement Ther Med; 2020 Mar; 49():102332. PubMed ID: 32147062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Chinese and Western Medicine for Coronary Heart Disease Prevention in Polycystic Ovary Syndrome: A 19-Year Nationwide Cohort Study.
    Liao CC; Chien CH; Yu TS; Li JM
    J Multidiscip Healthc; 2023; 16():3959-3973. PubMed ID: 38089784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome.
    Ong M; Peng J; Jin X; Qu X
    Am J Chin Med; 2017; 45(3):405-422. PubMed ID: 28359195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: a Bayesian modelling study.
    Ding T; Hardiman PJ; Petersen I; Baio G
    Hum Reprod; 2018 Jul; 33(7):1299-1306. PubMed ID: 29684121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Risk of Polycystic Ovary Syndrome in Taiwanese Women with Chronic Periodontitis: A Nationwide Population-Based Retrospective Cohort Study.
    Tong C; Wang YH; Yu HC; Chang YC
    J Womens Health (Larchmt); 2019 Oct; 28(10):1436-1441. PubMed ID: 31145020
    [No Abstract]   [Full Text] [Related]  

  • 13. Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome.
    Rubin KH; Glintborg D; Nybo M; Abrahamsen B; Andersen M
    J Clin Endocrinol Metab; 2017 Oct; 102(10):3848-3857. PubMed ID: 28938447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: A nationwide retrospective matched-cohort study.
    Hung KF; Hsu CP; Chiang JH; Lin HJ; Kuo YT; Sun MF; Yen HR
    J Ethnopharmacol; 2017 Mar; 199():168-174. PubMed ID: 28163114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Obesity on the Incidence of Type 2 Diabetes Among Women With Polycystic Ovary Syndrome.
    Kakoly NS; Earnest A; Teede HJ; Moran LJ; Joham AE
    Diabetes Care; 2019 Apr; 42(4):560-567. PubMed ID: 30705063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome.
    Shen CC; Yang AC; Hung JH; Hu LY; Tsai SJ
    Oncologist; 2015 Jan; 20(1):45-9. PubMed ID: 25410097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial.
    Kuek S; Wang WJ; Gui SQ
    Zhong Xi Yi Jie He Xue Bao; 2011 Sep; 9(9):965-72. PubMed ID: 21906521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chinese herbal medicine for subfertile women with polycystic ovarian syndrome.
    Zhang J; Li T; Zhou L; Tang L; Xu L; Wu T; Lim DC
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007535. PubMed ID: 20824862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Prevalence of Polycystic Ovary Syndrome in Type 1 Diabetes Mellitus Adolescents: Is There a Difference Depending on the NIH and Rotterdam Criteria?
    Busiah K; Colmenares A; Bidet M; Tubiana-Rufi N; Levy-Marchal C; Delcroix C; Jacquin P; Martin D; Benadjaoud L; Jacqz-Aigrain E; Laborde K; Robert JJ; Samara-Boustani D; Polak M
    Horm Res Paediatr; 2017; 87(5):333-341. PubMed ID: 28437788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical observation on treatment of 43 women with polycystic ovary syndrome based on syndrome differentiation].
    Jia LN; Wang XJ
    Zhong Xi Yi Jie He Xue Bao; 2006 Nov; 4(6):585-8. PubMed ID: 17090372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.